Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Gero Miesenböck, the Waynflete Professor of Physiology and Director of the Centre for Neural Circuits and Behaviour, is one of three scientists awarded The Shaw Prize in Life Science and Medicine.

None

Department of Physiology, Anatomy & Genetics (DPAG) Professor Gero Miesenböck has received The Shaw Prize in Life Science and Medicine 2020 "for the development of optogenetics, a technology that has revolutionized neuroscience."

Optogenetics is a technique that uses light to control the activity of nerve cells. It provides a direct means of probing the organisation of neural circuits and of identifying the brain processes underlying perception, action, emotion, and thought. Professor Miesenböck was the first to demonstrate optogenetic control of neural activity and animal behaviour. His foundational studies led to an explosion in optogenetic applications and technical improvements.The field has ultimately transformed neuroscientific research and opened new possibilities for the treatment of brain disorders. 

Read more on the Department of Physiology, Anatomy & Genetics website

Read more about The Shaw Prize on The Shaw Foundation website

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.